Literature DB >> 23671108

Dominant suppression of inflammation by glycan-hydrolyzed IgG.

Kutty Selva Nandakumar1, Mattias Collin, Kaisa E Happonen, Allyson M Croxford, Susanna L Lundström, Roman A Zubarev, Merrill J Rowley, Anna M Blom, Rikard Holmdahl.   

Abstract

A unique anti-inflammatory property of IgG, independent of antigen specificity, is described. IgG with modification of the heavy-chain glycan on asparagine 297 by the streptococcal enzyme endo-β-N-acetylglucosaminidase (EndoS) induced a dominant suppression of immune complex (IC)-mediated inflammation, such as arthritis, through destabilization of local ICs by fragment crystallizable-fragment crystallizable (Fc-Fc) interactions. Small amounts (250 µg) of EndoS-hydrolyzed IgG were sufficient to inhibit arthritis in mice and most effective during the formation of ICs in the target tissue. The presence of EndoS-hydrolyzed IgG disrupted larger IC lattice formation both in vitro and in vivo, as visualized with anti-C3b staining. Neither complement binding in vitro nor antigen-antibody binding per se was affected.

Entities:  

Keywords:  collagen; endoglycosidase; glycosylation; monoclonal antibody; rheumatoid arthritis

Mesh:

Substances:

Year:  2013        PMID: 23671108      PMCID: PMC3690874          DOI: 10.1073/pnas.1301480110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  The influence of glycosylation on the thermal stability and effector function expression of human IgG1-Fc: properties of a series of truncated glycoforms.

Authors:  Y Mimura; S Church; R Ghirlando; P R Ashton; S Dong; M Goodall; J Lund; R Jefferis
Journal:  Mol Immunol       Date:  2000 Aug-Sep       Impact factor: 4.407

2.  Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation.

Authors:  Yoshikatsu Kaneko; Falk Nimmerjahn; Jeffrey V Ravetch
Journal:  Science       Date:  2006-08-04       Impact factor: 47.728

3.  Multiple epitopes on cartilage type II collagen are accessible for antibody binding in vivo.

Authors:  R Holmdahl; J A Mo; R Jonsson; K Karlstrom; A Scheynius
Journal:  Autoimmunity       Date:  1991       Impact factor: 2.815

4.  Surface-bound anti-type II collagen-containing immune complexes induce production of tumor necrosis factor alpha, interleukin-1beta, and interleukin-8 from peripheral blood monocytes via Fc gamma receptor IIA: a potential pathophysiologic mechanism for humoral anti-type II collagen immunity in arthritis.

Authors:  Mohammed Mullazehi; Linda Mathsson; Jon Lampa; Johan Rönnelid
Journal:  Arthritis Rheum       Date:  2006-06

5.  The role of Fc:Fc interactions in insoluble immune complex formation and complement activation.

Authors:  S B Easterbrook-Smith; R J Vandenberg; J R Alden
Journal:  Mol Immunol       Date:  1988-12       Impact factor: 4.407

6.  Interactions between precipitating and nonprecipitating antibodies in the formation of immune complexes.

Authors:  F G Cosio; D J Birmingham; D J Sexton; L A Hebert
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

7.  Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9- and 2.8-A resolution.

Authors:  J Deisenhofer
Journal:  Biochemistry       Date:  1981-04-28       Impact factor: 3.162

8.  Characterisation of the size and composition of circulating immune complexes in patients with rheumatoid arthritis.

Authors:  R A Mageed; J R Kirwan; P W Thompson; D A McCarthy; E J Holborow
Journal:  Ann Rheum Dis       Date:  1991-04       Impact factor: 19.103

9.  Passive transfer of arthritis to mice by injection of human anti-type II collagen antibody.

Authors:  P H Wooley; H S Luthra; S K Singh; A R Huse; J M Stuart; C S David
Journal:  Mayo Clin Proc       Date:  1984-11       Impact factor: 7.616

10.  The factor H variant associated with age-related macular degeneration (His-384) and the non-disease-associated form bind differentially to C-reactive protein, fibromodulin, DNA, and necrotic cells.

Authors:  Andreas P Sjöberg; Leendert A Trouw; Simon J Clark; Jonatan Sjölander; Dick Heinegård; Robert B Sim; Anthony J Day; Anna M Blom
Journal:  J Biol Chem       Date:  2007-02-09       Impact factor: 5.157

View more
  9 in total

Review 1.  Intravenous immunoglobulin-mediated immunosuppression and the development of an IVIG substitute.

Authors:  Miglena G Prabagar; Hyeong-jwa Choi; Jin-Yeon Park; Sohee Loh; Young-Sun Kang
Journal:  Clin Exp Med       Date:  2013-09-01       Impact factor: 3.984

2.  Therapeutic potential of deglycosylated antibodies.

Authors:  Max Crispin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-07       Impact factor: 11.205

Review 3.  Targeting B cells and autoantibodies in the therapy of autoimmune diseases.

Authors:  Daniela Kao; Anja Lux; Inessa Schwab; Falk Nimmerjahn
Journal:  Semin Immunopathol       Date:  2014-04-29       Impact factor: 9.623

Review 4.  Role of siglecs and related glycan-binding proteins in immune responses and immunoregulation.

Authors:  Bruce S Bochner; Nives Zimmermann
Journal:  J Allergy Clin Immunol       Date:  2015-01-13       Impact factor: 10.793

5.  GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.

Authors:  Leander Meuris; Francis Santens; Greg Elson; Nele Festjens; Morgane Boone; Anaëlle Dos Santos; Simon Devos; François Rousseau; Evelyn Plets; Erica Houthuys; Pauline Malinge; Giovanni Magistrelli; Laura Cons; Laurence Chatel; Bart Devreese; Nico Callewaert
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

Review 6.  The Role of Posttranslational Protein Modifications in Rheumatological Diseases: Focus on Rheumatoid Arthritis.

Authors:  Andrea Mastrangelo; Tania Colasanti; Cristiana Barbati; Arbi Pecani; Danilo Sabatinelli; Monica Pendolino; Simona Truglia; Laura Massaro; Riccardo Mancini; Francesca Miranda; Francesca Romana Spinelli; Fabrizio Conti; Cristiano Alessandri
Journal:  J Immunol Res       Date:  2015-05-18       Impact factor: 4.818

7.  Streptococcal Endo-β-N-Acetylglucosaminidase Suppresses Antibody-Mediated Inflammation In Vivo.

Authors:  Kutty Selva Nandakumar; Mattias Collin; Kaisa E Happonen; Susanna L Lundström; Allyson M Croxford; Bingze Xu; Roman A Zubarev; Merrill J Rowley; Anna M Blom; Christian Kjellman; Rikard Holmdahl
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

8.  Fragments of bacterial endoglycosidase s and immunoglobulin g reveal subdomains of each that contribute to deglycosylation.

Authors:  Emma V Dixon; Jolyon K Claridge; David J Harvey; Kavitha Baruah; Xiaojie Yu; Snezana Vesiljevic; Susan Mattick; Laura K Pritchard; Benjamin Krishna; Christopher N Scanlan; Jason R Schnell; Matthew K Higgins; Nicole Zitzmann; Max Crispin
Journal:  J Biol Chem       Date:  2014-03-25       Impact factor: 5.157

9.  Profiling IgG N-glycans as potential biomarker of chronological and biological ages: A community-based study in a Han Chinese population.

Authors:  Xinwei Yu; Youxin Wang; Jasminka Kristic; Jing Dong; Xi Chu; Siqi Ge; Hao Wang; Honghong Fang; Qing Gao; Di Liu; Zhongyao Zhao; Hongli Peng; Maja Pucic Bakovic; Lijuan Wu; Manshu Song; Igor Rudan; Harry Campbell; Gordan Lauc; Wei Wang
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.